Concepts (49)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electrical Equipment and Supplies | 1 | 2022 | 3 | 0.780 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2022 | 37 | 0.760 |
Why?
|
| Lupus Erythematosus, Systemic | 4 | 2012 | 992 | 0.200 |
Why?
|
| Radiation Oncology | 1 | 2023 | 19 | 0.200 |
Why?
|
| Radiometry | 1 | 2022 | 45 | 0.190 |
Why?
|
| Radiotherapy Dosage | 1 | 2022 | 104 | 0.190 |
Why?
|
| Phantoms, Imaging | 1 | 2022 | 100 | 0.190 |
Why?
|
| Software | 1 | 2022 | 126 | 0.180 |
Why?
|
| Lymphoma, B-Cell, Marginal Zone | 1 | 2018 | 12 | 0.140 |
Why?
|
| Angiogenesis Inhibitors | 1 | 2018 | 108 | 0.130 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2009 | 550 | 0.130 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2012 | 50 | 0.100 |
Why?
|
| Antibody Specificity | 1 | 2012 | 114 | 0.090 |
Why?
|
| Interferon Regulatory Factors | 1 | 2012 | 58 | 0.090 |
Why?
|
| Humans | 7 | 2023 | 28581 | 0.080 |
Why?
|
| B-Lymphocytes | 1 | 2012 | 285 | 0.080 |
Why?
|
| Genetic Predisposition to Disease | 2 | 2012 | 671 | 0.080 |
Why?
|
| Autoantibodies | 1 | 2012 | 479 | 0.080 |
Why?
|
| src-Family Kinases | 1 | 2009 | 71 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2009 | 163 | 0.070 |
Why?
|
| Membrane Proteins | 1 | 2009 | 485 | 0.060 |
Why?
|
| Case-Control Studies | 3 | 2012 | 732 | 0.050 |
Why?
|
| Leadership | 1 | 2023 | 54 | 0.050 |
Why?
|
| Neck | 1 | 2018 | 26 | 0.040 |
Why?
|
| Lymph Nodes | 1 | 2018 | 103 | 0.030 |
Why?
|
| Recurrence | 1 | 2018 | 325 | 0.030 |
Why?
|
| Female | 4 | 2018 | 15471 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2018 | 478 | 0.030 |
Why?
|
| Middle Aged | 2 | 2018 | 7310 | 0.030 |
Why?
|
| Immunodiffusion | 1 | 2012 | 12 | 0.020 |
Why?
|
| Seroepidemiologic Studies | 1 | 2012 | 10 | 0.020 |
Why?
|
| Ribosomal Proteins | 1 | 2012 | 20 | 0.020 |
Why?
|
| Asian Americans | 1 | 2012 | 40 | 0.020 |
Why?
|
| Family | 1 | 2012 | 98 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2012 | 49 | 0.020 |
Why?
|
| Interferons | 1 | 2012 | 70 | 0.020 |
Why?
|
| Antibodies, Antinuclear | 1 | 2012 | 183 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2018 | 2402 | 0.020 |
Why?
|
| Haplotypes | 1 | 2012 | 284 | 0.020 |
Why?
|
| African Americans | 1 | 2012 | 352 | 0.020 |
Why?
|
| Gene Expression Profiling | 1 | 2012 | 453 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2012 | 1009 | 0.020 |
Why?
|
| Genome-Wide Association Study | 1 | 2009 | 233 | 0.020 |
Why?
|
| Age Factors | 1 | 2009 | 734 | 0.020 |
Why?
|
| United States | 1 | 2012 | 2201 | 0.020 |
Why?
|
| Signal Transduction | 1 | 2012 | 1454 | 0.010 |
Why?
|
| Aged | 1 | 2012 | 5525 | 0.010 |
Why?
|
| Adult | 1 | 2012 | 7922 | 0.010 |
Why?
|
| Male | 1 | 2012 | 13771 | 0.010 |
Why?
|